This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
E. Claiborne Robins Company, Inc.
E. Claiborne Robins Company, Inc., commonly referred to as Robins, is a distinguished leader in the pharmaceutical and healthcare industry, headquartered in the United States. Founded in 1947, the company has established a strong presence across major operational regions, focusing on innovative solutions in drug delivery and medical devices. Robins is renowned for its core products, which include advanced drug formulation technologies and specialised medical equipment. These offerings are distinguished by their commitment to quality and efficacy, setting the company apart in a competitive market. Over the years, E. Claiborne Robins Company has achieved significant milestones, solidifying its reputation as a trusted partner in healthcare innovation. With a focus on enhancing patient outcomes, Robins continues to play a pivotal role in shaping the future of the pharmaceutical landscape.
DitchCarbon Score
How does E. Claiborne Robins Company, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
E. Claiborne Robins Company, Inc.'s score of 40 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
E. Claiborne Robins Company, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Bausch Health Companies Inc., which influences its climate commitments and emissions reporting. As part of its corporate family, E. Claiborne Robins Company, Inc. inherits emissions data and reduction initiatives from Bausch Health Companies Inc. However, no specific reduction targets or achievements have been documented for E. Claiborne Robins Company, Inc. itself. The company does not have any documented climate pledges or specific initiatives aimed at reducing carbon emissions. In the context of climate commitments, E. Claiborne Robins Company, Inc. aligns with the broader sustainability goals set by its parent company, Bausch Health Companies Inc., which may include industry-standard climate initiatives such as Science Based Targets (SBTi) and participation in the Carbon Disclosure Project (CDP). However, specific details regarding these initiatives and their impact on E. Claiborne Robins Company, Inc. are not available. Overall, while E. Claiborne Robins Company, Inc. is positioned within a corporate structure that prioritises climate action, specific emissions data and reduction targets for the company remain unspecified.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 46,686,000 | 00,000,000 |
| Scope 2 | 50,513,000 | 00,000,000 |
| Scope 3 | 19,260,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
E. Claiborne Robins Company, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
